BackGRI Bio Overview

GRI Bio Current Cash

GRI Bio's current cash is $8.2M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$8.23M
63.66% YoYΔ $3.20M vs prior year quarter

Peer average

Loading

GRI Bio Current Cash History

Loading

GRI Bio vs. peers: Current Cash Comparison

Loading

GRI Bio Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GRI Bio (GRI) FAQ

GRI Bio (GRI) currently reports a current cash of $8.2M as of January 2026. That compares with $5M in the prior-year period — up 63.7% year over year. Use the charts on this page to explore GRI Bio's current cash history and peer comparisons.

GRI Bio's current cash increased from $5M to $8.2M — a 63.7% year-over-year increase (period ending January 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GRI Bio reported $8.2M in current cash as of January 2026. That compares with $5M in the prior-year period — up 63.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $8.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GRI Bio, and consider following GRI for alerts when major investors trade the stock.

GRI Bio is classified in the Healthcare sector. On current cash, it currently shows $8.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GRI with unrelated industries.